<PAGE> 1
FORM 3 OMB APPROVAL
OMB NUMBER 3235-0104
EXPIRES: SEPTEMBER 30, 1998
ESTIMATED AVERAGE
BURDEN HOURS PER
RESPONSE.....0.5
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or Section
30(f) of the Investment Company Act of 1940
1. Name and Address of Reporting Person
Bergman, M.D. Garrett E.
(Last) (First) (Middle)
c/o InKine Pharmaceutical Company, Inc.
Sentry Park East, 1720 Walton Road
(Street)
Blue Bell, PA 19422
(City) (State) (Zip)
2. Date of Event Requiring Statement
(Month/Day/Year)
2/2/98
3. IRS or Social Security
Number of Reporting Person (Voluntary)
4. Issuer Name and Ticker or Trading Symbol
InKine Pharmaceutical Company, Inc. (INKP)
5. Relationship of Reporting Person to Issuer
(Check all applicable)
Director 10% Owner
----- ------
X Officer (give title below) Other (specify below)
------ ------
Vice President, Clinical Research
and Regulatory Affairs
6. If Amendment, Date of Original (Month/Day/Year)
7. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
----
Form filed by More than One Reporting Person
----
TABLE I - NON-DERIVATIVE SECURITIES BENEFICIALLY OWNED
<TABLE>
<CAPTION>
1. Title of Security 2. Amount of Securities 3. Ownership Form: 4. Nature of Indirect Beneficial
(Instr. 4) Beneficially Owned Direct (D) or Ownership (Instr. 5)
(Instr. 4) Indirect (I)
(Instr. 5)
- ---------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
None
- ---------------------------------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------------------------------------
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly. *If the form is filed by more than one reporting
person, see Instruction 5(b)(v).
(Over)
SEC 1473 (7-96)
<PAGE> 2
FORM 3 (continued)
TABLE II - DERIVATIVE SECURITIES BENEFICIALLY OWNED (E.G.,
PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)
<TABLE>
<CAPTION>
1. Title of Derivative Security 2. Date Exercisable and Expiration 3. Title and Amount of Securities Underlying
(Instr. 4) Date (Month/Day/Year) Derivative Security (Instr. 4)
Amount or
Date Exercisable Expiration Number of Shares
Date Title
- ---------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
Stock Option (Right to Buy) * 1/29/08 Common Stock 74,500
- ---------------------------------------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------------------------------------------
</TABLE>
<TABLE>
<CAPTION>
4. Conversion or 5. Ownership Form of 6. Nature of Indirect
Exercise Price of Derivative Security: Beneficial Ownership
Derivative Direct (D) or (Instr. 5)
Security Indirect (I)
(Instr. 5)
- -----------------------------------------------------------------------------------------------------------------------------
<S> <C> <C>
$1.00 D
- -----------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------
</TABLE>
Explanation of Responses:
* Option becomes exerciseable in annual increments of 25% commencing on
January 29, 1999.
** Intentional misstatements or omissions of facts constitute Federal
Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
/s/ GARRETT E. BERGMAN 2/9/98
---------------------- ------
** Signature of Reporting Person Date
Garrett E. Bergman, M.D.
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, See Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB Number.
Page 2
SEC 1473 (7-96)